SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer

Figure 4

Relationship between SPARCL1 and clinicopathological features in CRC patients in published clinical studies. The correlation of SPARCL1 expression with (a) tumor differentiation, (b) tumor stage, (c) distant metastasis, (d) lymph node metastasis, and (e) overall survival.

(a)

(b)

(c)

(d)

(e)